These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28650924)

  • 1. Comparison of Approaches for Notification and Authorization in Pragmatic Clinical Research Evaluating Commonly Used Medical Practices.
    Weinfurt KP; Bollinger JM; Brelsford KM; Bresciani M; Lampron Z; Lin L; Topazian RJ; Sugarman J
    Med Care; 2017 Nov; 55(11):970-978. PubMed ID: 28650924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.
    Courtright KR; Halpern SD; Joffe S; Ellenberg SS; Karlawish J; Madden V; Gabler NB; Szymanski S; Yadav KN; Dember LM
    Trials; 2017 Oct; 18(1):474. PubMed ID: 29020994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who is willing to participate in low-risk pragmatic clinical trials without consent?
    Dal-Ré R; Carcas AJ; Carné X
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1557-1563. PubMed ID: 28900674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public preferences on written informed consent for low-risk pragmatic clinical trials in Spain.
    Dal-Ré R; Carcas AJ; Carné X; Wendler D
    Br J Clin Pharmacol; 2017 Sep; 83(9):1921-1931. PubMed ID: 28419518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Views Concerning Research on Medical Practices: Implications for Consent.
    Weinfurt KP; Bollinger JM; Brelsford KM; Crayton TJ; Topazian RJ; Kass NE; Beskow LM; Sugarman J
    AJOB Empir Bioeth; 2016; 7(2):76-91. PubMed ID: 27800531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic Randomized Trials Without Standard Informed Consent?: A National Survey.
    Nayak RK; Wendler D; Miller FG; Kim SY
    Ann Intern Med; 2015 Sep; 163(5):356-64. PubMed ID: 26215125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding preferences regarding consent for pragmatic trials in acute care.
    Dickert NW; Wendler D; Devireddy CM; Goldkind SF; Ko YA; Speight CD; Kim SY
    Clin Trials; 2018 Dec; 15(6):567-578. PubMed ID: 30280582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' beliefs regarding informed consent for low-risk pragmatic trials.
    Dal-Ré R; Carcas AJ; Carné X; Wendler D
    BMC Med Res Methodol; 2017 Sep; 17(1):145. PubMed ID: 28923007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes Toward Risk and Informed Consent for Research on Medical Practices: A Cross-sectional Survey.
    Cho MK; Magnus D; Constantine M; Lee SS; Kelley M; Alessi S; Korngiebel D; James C; Kuwana E; Gallagher TH; Diekema D; Capron AM; Joffe S; Wilfond BS
    Ann Intern Med; 2015 May; 162(10):690-6. PubMed ID: 25868119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.
    Miller DG; Kim SYH; Li X; Dickert NW; Flory J; Runge CP; Relton C
    JAMA Netw Open; 2018 Dec; 1(8):e186149. PubMed ID: 30646316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Factors Predict Willingness to Join Low-Risk Pragmatic Clinical Trials?
    Morain SR; Kass NE; Faden RR
    Ethics Hum Res; 2021 Jan; 43(1):17-24. PubMed ID: 33463074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it important to disclose how treatments are selected in clinical research and clinical care?
    Nayak RK; Wendler D
    AJOB Empir Bioeth; 2017; 8(3):170-177. PubMed ID: 28949900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholders' Views of Alternatives to Prospective Informed Consent for Minimal-Risk Pragmatic Comparative Effectiveness Trials.
    Whicher D; Kass N; Faden R
    J Law Med Ethics; 2015; 43(2):397-409. PubMed ID: 26242962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of cohort-specific consent and patient control in phase I cancer trials.
    Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
    J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Partner Perspectives Regarding Ethically and Clinically Important Aspects of Trial Design in Pragmatic Cluster Randomized Trials for Hemodialysis.
    Nicholls SG; Carroll K; Goldstein CE; Brehaut JC; Weijer C; Zwarenstein M; Dixon S; Grimshaw JM; Garg AX; Taljaard M
    Can J Kidney Health Dis; 2021; 8():20543581211032818. PubMed ID: 34367647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials.
    Chen SC; Kim SY
    Clin Trials; 2016 Dec; 13(6):605-611. PubMed ID: 27365010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leave me out: Patients' characteristics and reasons for opting out of a pragmatic clinical trial involving medication adherence.
    Sandy LC; Glorioso TJ; Weinfurt K; Sugarman J; Peterson PN; Glasgow RE; Ho PM
    Medicine (Baltimore); 2021 Dec; 100(51):e28136. PubMed ID: 34941059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HIPAA authorization on willingness to participate in clinical research.
    Dunlop AL; Graham T; Leroy Z; Glanz K; Dunlop B
    Ann Epidemiol; 2007 Nov; 17(11):899-905. PubMed ID: 17689261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient attitudes toward granting consent to participate in perioperative randomized clinical trials.
    Patel A; Wilke HJ; Mingay D; Ellis JE
    J Clin Anesth; 2004 Sep; 16(6):426-34. PubMed ID: 15567646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.